Human Immunodeficiency Virus
Human Immunodeficiency Virus (HIV) is a virus that attacks the immune system, leading to a decreased ability to fight off infections and potentially progressing to Acquired Immunodeficiency Syndrome (AIDS), where the immune system fails progressively, allowing life-threatening opportunistic infections and cancers to thrive. Without treatment, the average survival time after HIV infection is estimated to be 9 to 11 years.
Health Outcomes
- Altered CD4+ T-cell Cytokine Levels
- Altered Neutrophil Fungicidal Function
- Changed Hematology Parameter
- Changed Vaginal Microbiota Composition
- Co-Aggregation with Pathogens
- Delayed Onset of Thrombocytopenia
- Enhanced Immune Evasion
- Enhanced Vaginal Immune Defense
- Improved Antiviral Effect
- Improved Antiviral Immune Response
- Improved Antiviral Response
- Improved CD4+/CD8+ Ratio
- Improved Cervical HPV Clearance
- Improved Cervical Lesion Resolution
- Improved Cure Rate
- Improved Energy Availability
- Improved Host Health
- Improved Immune Activation
- Improved Lower Limit of Detection
- Improved Lymphocyte Count
- Improved Medication Adherence
- Improved Neutrophil Function
- Improved Relative Survival Rate Against Pathogen
- Improved Resistance to Viral Infections
- Improved Seroconversion
- Improved Vaccine Efficacy
- Improved Vaccine Seroconversion
- Improved Vaginal Barrier Integrity
- Increased Antibody Response
- Increased CD4 Counts
- Increased CD4-CD8 Ratio
- Increased CD8 Percentage
- Increased Candida albicans Eradication
- Increased Expression of Activation Markers on NK Cells
- Increased Infection
- Increased Infection Frequency
- Increased Memory T Cell Frequency
- Increased Sepsis
- Increased Susceptibility to Salmonella Infection
- Increased Trichomonas Vaginalis Growth
- Modulated Immune Cell Activity
- No Antiviral Effect
- No Measurable IFN-Alpha Induction
- Probiotic-Related Infection
- Reduced Adherence Attrition
- Reduced Adipose Tissue Wasting
- Reduced Anti-Listeria Effect
- Reduced Antilisterial Activity
- Reduced BCG Phagocytic Intake
- Reduced CD4+ T Cell Count in Draining Lymph Nodes
- Reduced CD8 Cell Percentage
- Reduced COVID-19 Immune Support Needs
- Reduced Candida Albicans Survival
- Reduced Circulating Monocytes
- Reduced Disease Progression
- Reduced Fat-Free Mass
- Reduced Immune Activation
- Reduced Immune Cell Activity
- Reduced Immune Protection
- Reduced Immunogenicity After Oral Vaccination
- Reduced Immunosuppression
- Reduced Incidence of Bacterial Pneumonia
- Reduced Infection Frequency
- Reduced Infectious Complication
- Reduced Listeria Monocytogenes Survival
- Reduced Mycobacterium bovis BCG Phagocytic Uptake
- Reduced Oral Candida Colonization
- Reduced Salivary HNP1-3 Secretion Rate
- Reduced Susceptibility to Bacterial Infection
- Reduced T-Effector Memory Cell Activity
- Reduced Thrombocytopenia
- Reduced Total Infections
- Reduced Toxoplasma gondii Burden
- Reduced Treatment Failure Rate
- Reduced Vaginal Colonization
- Reduced Vaginal Inflammation
- Reduced Viral Activity
- Reduced Viral Binding
- Reduced Viral Clearance Time
- Reduced Viral Infection
- Reduced Viral Infection Incidence
- Reduced Viral Load
- Reduced Viral Load in Epithelial Cells
- Reduced Virulence of Pathogens
- Reduced White Blood Cell Count
- Reduced Zinc Level
- Regressed Esophagitis
- White Blood Cell Count